Radiation Pharmacogenomics Identifies Biomarkers that Could Personalize Cancer Treatment, Mayo Clinic Study Finds

EurekAlert! -- October 5, 2010 – Radiation therapy is used to treat more than half of all cancer cases, but patient response to therapy can vary greatly. Genetics is increasingly being recognized as a significant contributor to inter-individual response to radiation, but the biology underlying response remains poorly understood. In a study published online today in Genome Research (www.genome.org), researchers employed a pharmacogenomics approach to find biomarkers associated with radiation response that could help to more effectively tailor individual cancer treatments in the future.